TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16177470

Group type: EXPERIMENTAL
Intervention: Oral misoprostol (0.8 mg) after mifepristone (200 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (0.8 mg) after mifepristone (200 mg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Continued oral misoprostol (0.4 mg twice daily for 7 days)
Number of subjects: 150
Study: 12502670

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 10094948

Group type: EXPERIMENTAL
Intervention: 0.02 mg/kg midazolam
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.03 mg/kg midazolam
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8750486

Group type: EXPERIMENTAL
Intervention: gentamycin plus clindamycin (N = 40)
Number of subjects: 78

Group type: COMPARATOR
Intervention: ceftazidime plus doxycycline (N = 36)
Number of subjects: 78
Study: 1869374

Group type: EXPERIMENTAL
Intervention: Radial incision
Number of subjects: 228

Group type: COMPARATOR
Intervention: Circumferential incision
Number of subjects: 228
Study: 6355050

Group type: EXPERIMENTAL
Intervention: Topical acyclovir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous acyclovir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Steroids
Number of subjects: 0
Study: 30883913

Group type: EXPERIMENTAL
Intervention: Hair cortisol concentrations (HCC) in participants with PTSD
Number of subjects: 28

Group type: COMPARATOR
Intervention: Hair cortisol concentrations (HCC) in trauma-exposed controls
Number of subjects: 28
Study: 29807962

Group type: EXPERIMENTAL
Intervention: 0.8% hyaluronic acid gel (GENGIGEL®) applied subgingivally after scaling and root planing (SRP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control sites (no hyaluronic acid gel)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.8% hyaluronic acid gel (GENGIGEL®)
Number of subjects: 24
Study: 27316678

Group type: EXPERIMENTAL
Intervention: 12-week anti-inflammatory diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 24704648

Group type: EXPERIMENTAL
Intervention: Smartphone group (modified chest compression method)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Traditional group (standardized chest compression method)
Number of subjects: 64
Study: 22468861

Group type: EXPERIMENTAL
Intervention: BIAsp 30 (6 U)
Number of subjects: 323

Group type: COMPARATOR
Intervention: BHI 30 (6 U)
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: BIAsp 30
Number of subjects: 323

Group type: COMPARATOR
Intervention: BHI 30
Number of subjects: 323
Study: 20502866

Group type: EXPERIMENTAL
Intervention: Probiotics (Ergyphilus, 2 x 10(10) lactic acid bacteria, mostly Lactobacillus rhamnosus GG, once a day)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 167
Study: 17916258

Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg/d
Number of subjects: 756

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 756
Study: 16005902

Group type: EXPERIMENTAL
Intervention: 60 mg fasudil, intravenous injection over 60 min, twice daily for 14 days
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo (saline), intravenous injection over 60 min, twice daily for 14 days
Number of subjects: 160
Study: 12435254

Group type: EXPERIMENTAL
Intervention: Clopidogrel loading dose (300 mg) followed by clopidogrel (75 mg/d) for 12 months
Number of subjects: 2116

Group type: COMPARATOR
Intervention: Placebo followed by placebo for 12 months
Number of subjects: 2116

Group type: EXPERIMENTAL
Intervention: Clopidogrel loading dose (300 mg) given at least 6 hours before PCI
Number of subjects: 2116

Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg/d)
Number of subjects: 2116
Study: 10604294

Group type: EXPERIMENTAL
Intervention: High-tension glaucoma
Number of subjects: 46

Group type: COMPARATOR
Intervention: Normal-tension glaucoma
Number of subjects: 46
Study: 7496640

Group type: EXPERIMENTAL
Intervention: Treatment for major depressive disorder (specific treatments not detailed), lasting 16 weeks.
Number of subjects: 113
Study: 1685465

Group type: EXPERIMENTAL
Intervention: cimetidine 800 mg at night (n=8)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: ranitidine 150 mg twice daily (n=10)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg at night (n=12)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: nizatidine 300 mg at night (n=8)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: famotidine 40 mg at night (n=8)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: All regimens
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Whole group after stopping H2 blockade
Number of subjects: 46
Study: 6800539

Group type: EXPERIMENTAL
Intervention: Hospital outpatient care
Number of subjects: 376

Group type: COMPARATOR
Intervention: General practice care
Number of subjects: 376
Study: 29501366

Group type: EXPERIMENTAL
Intervention: Nedaplatin 100 mg/m2 on days 1, 22, and 43 for three cycles concurrently with intensity-modulated radiotherapy
Number of subjects: 402

Group type: COMPARATOR
Intervention: Cisplatin 100 mg/m2 on days 1, 22, and 43 for three cycles concurrently with intensity-modulated radiotherapy
Number of subjects: 402

Group type: COMPARATOR
Intervention: Cisplatin
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Nedaplatin
Number of subjects: 402
Study: 28753943

Group type: EXPERIMENTAL
Intervention: Low-caffeine green tea (LCGT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard green tea (SGT)
Number of subjects: 20
Study: 26201996

Group type: EXPERIMENTAL
Intervention: Topical 1.5% dexamethasone γ‐cyclodextrin nanoparticle eye drops (DexNP)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Posterior subtenon injection of 20 mg triamcinolone acetonide
Number of subjects: 22
Study: 23902884

Group type: EXPERIMENTAL
Intervention: BBAVF
Number of subjects: 61

Group type: COMPARATOR
Intervention: AVG
Number of subjects: 61
Study: 20626389

Group type: EXPERIMENTAL
Intervention: Transdermal oxybutynin 3.9 mg/day
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 18942245

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ultrasound-localized technique
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 100
Study: 16507192

Group type: EXPERIMENTAL
Intervention: Isoflurane 2.5 minimum alveolar concentration for 15 min
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (isoflurane-free cardiopulmonary bypass)
Number of subjects: 40
Study: 15255620

Group type: EXPERIMENTAL
Intervention: Hypertensive subjects
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Captopril and Losartan (A.C.E. inhibitors and A.II.R. antagonists)
Number of subjects: 120
Study: 11103560

Group type: EXPERIMENTAL
Intervention: Health promotion lesson modules implemented in the intervention school between T1 and T2 (12 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health promotion lesson modules
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health promotion activities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participation in longitudinal study
Number of subjects: 0
Study: 9132327

Group type: EXPERIMENTAL
Intervention: Plasma endothelin-1 (ET-1) levels in patients with BD
Number of subjects: 27

Group type: COMPARATOR
Intervention: Plasma endothelin-1 (ET-1) levels in healthy controls
Number of subjects: 27
Study: 7911639

Group type: EXPERIMENTAL
Intervention: Acetazolamide administration
Number of subjects: 12
Study: 3949595

Group type: EXPERIMENTAL
Intervention: Depressive subjects
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-depressive psychiatric subjects
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All subjects considered on the same continuum of depression
Number of subjects: 30
Study: 29465495

Group type: COMPARATOR
Intervention: Supervised treadmill exercise
Number of subjects: 1547

Group type: COMPARATOR
Intervention: Home-based walking exercise interventions incorporating behavioral change techniques
Number of subjects: 1547

Group type: COMPARATOR
Intervention: Home-based walking exercise
Number of subjects: 1547

Group type: COMPARATOR
Intervention: Upper and lower extremity ergometry
Number of subjects: 1547

Group type: EXPERIMENTAL
Intervention: Supervised treadmill exercise (12 weeks, 36 sessions)
Number of subjects: 1547
Study: 26510709

Group type: EXPERIMENTAL
Intervention: Bitter-tasting phenylalanine-free l-amino acid exposure
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (healthy children), N=35
Number of subjects: 35
Study: 25492853

Group type: EXPERIMENTAL
Intervention: Active interferential current + Pilates (n=74)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Sham interferential current + Pilates (n=74)
Number of subjects: 148
Study: 23075413

Group type: EXPERIMENTAL
Intervention: Erzhi Tiangui Granule (ETG)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo granules
Number of subjects: 66
Study: 18607714

Group type: EXPERIMENTAL
Intervention: Expressive writing about traumatic experiences
Number of subjects: 37

Group type: COMPARATOR
Intervention: Expressive writing about trivial topics
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Expressive writing (both groups)
Number of subjects: 37
Study: 18067973

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT) plus pharmacotherapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Clinical Management (CM)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 45
Study: 16884957

Group type: EXPERIMENTAL
Intervention: Liaison (LS) schools
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Champion (CS) schools
Number of subjects: 10

Group type: COMPARATOR
Intervention: Usual Practice (UP) schools
Number of subjects: 10
Study: 12538507

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Idoxifene
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fulvestrant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4-hydroxyandrostenedione (aromatase inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 0
Study: 10800604

Group type: EXPERIMENTAL
Intervention: Artificial tear ointment applied to one eye
Number of subjects: 50

Group type: COMPARATOR
Intervention: Passive closure of the eyelid (control eye)
Number of subjects: 50
Study: 8645677

Group type: EXPERIMENTAL
Intervention: Amphotericin B (10 mg lozenges, four times daily for 14 days)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Fluconazole (50 mg daily for 7 days)
Number of subjects: 73
Study: 1524175

Group type: EXPERIMENTAL
Intervention: Oral clonidine, mean dose 3.6 micrograms/kg (n = 28)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Oral diazepam, 0.2 mg/kg (n = 30)
Number of subjects: 58
Study: 2996991

Group type: EXPERIMENTAL
Intervention: Low residue diet
Number of subjects: 70

Group type: COMPARATOR
Intervention: Normal Italian diet
Number of subjects: 70
Study: 30992220

Group type: EXPERIMENTAL
Intervention: Intratracheal administration of human umbilical cord blood-derived mesenchymal stromal cells
Number of subjects: 12
Study: 29317229

Group type: EXPERIMENTAL
Intervention: Music for pain reduction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Provider assessment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Previous abortion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immediate intrauterine device insertion
Number of subjects: 0
Study: 26992129

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy plus Amitriptyline
Number of subjects: 135

Group type: COMPARATOR
Intervention: Headache Education plus Amitriptyline
Number of subjects: 135
Study: 24014167

Group type: EXPERIMENTAL
Intervention: Youth Matters (YM) bullying prevention trial
Number of subjects: 1077

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1077

Group type: EXPERIMENTAL
Intervention: YM group
Number of subjects: 1077
Study: 22476387

Group type: EXPERIMENTAL
Intervention: Vorapaxar 40 mg coadministered with warfarin 25 mg (Day 7) after multiple doses of vorapaxar 2.5 mg/day on Days 1-6
Number of subjects: 12

Group type: COMPARATOR
Intervention: Warfarin 25 mg (Day 1)
Number of subjects: 12
Study: 20127832

Group type: EXPERIMENTAL
Intervention: Positive SEBST
Number of subjects: 597

Group type: COMPARATOR
Intervention: Negative SEBST
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Urodynamic measures (VLPP, MUCP)
Number of subjects: 597
Study: 17988199

Group type: EXPERIMENTAL
Intervention: L‐T4 (Levothyroxine) treatment, N=20
Number of subjects: 37

Group type: COMPARATOR
Intervention: Untreated group, N=17
Number of subjects: 37
Study: 16685066

Group type: EXPERIMENTAL
Intervention: Probiotic group (Lactobacillus rhamnosus LC705 and Propionibacterium freudenreichii subsp. shermanii strains, 2 times/d for 5 weeks)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 90
Study: 12842681

Group type: EXPERIMENTAL
Intervention: Fentanyl 2 microg/kg intravenous bolus given 5 minutes before retrobulbar anesthesia
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no fentanyl)
Number of subjects: 120
Study: 10915749

Group type: COMPARATOR
Intervention: Interferon alfa‐2b and placebo
Number of subjects: 1744

Group type: EXPERIMENTAL
Intervention: Combination interferon alfa‐2b and ribavirin
Number of subjects: 1744
Study: 8840373

Group type: EXPERIMENTAL
Intervention: TMP-SMX (oral)
Number of subjects: 9

Group type: COMPARATOR
Intervention: TMP-SMX (IV)
Number of subjects: 9
Study: 1738570

Group type: EXPERIMENTAL
Intervention: s‐CT (200 IU infusion)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 21
Study: 6438935

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of 0.2 mg nifedipine and 10 mg sublingual nifedipine (group I)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of 0.4 mg 3‐N‐morpholinosyndnonimine (SIN‐1) (group II)
Number of subjects: 28
Study: 31939365

Group type: EXPERIMENTAL
Intervention: CollaCote® membrane
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: PRF membrane
Number of subjects: 20
Study: 25420063

Group type: EXPERIMENTAL
Intervention: Point-of-purchase intervention (signage)
Number of subjects: 128
Study: 23412170

Group type: EXPERIMENTAL
Intervention: Intra-articular PRP injection
Number of subjects: 65
Study: 21226958

Group type: EXPERIMENTAL
Intervention: Exercise intervention (≥ 900 kcal/wk)
Number of subjects: 50
Study: 18299491

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (0.625 mg/d) plus medroxyprogesterone acetate (2.5 mg/d)
Number of subjects: 16608

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16608

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens plus medroxyprogesterone acetate
Number of subjects: 16608

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens plus medroxyprogesterone acetate after discontinuation
Number of subjects: 16608
Study: 16565035

Group type: EXPERIMENTAL
Intervention: Strategy training
Number of subjects: 113

Group type: COMPARATOR
Intervention: Occupational therapy as usual
Number of subjects: 113
Study: 14525822

Group type: EXPERIMENTAL
Intervention: 0.5% amethocaine
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 0.5% ketorolac
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 51
Study: 10898674

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg orally every 24 hours for 2 days prior to surgery, followed by 500 mg as an hour-long intravenous infusion on the day of surgery.
Number of subjects: 0
Study: 8606269

Group type: EXPERIMENTAL
Intervention: Exercise-induced ventricular arrhythmias in group A (30 patients)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Postexercise SPECT in group A (30 patients)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Postexercise SPECT in group B (30 patients)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Uptake of F-18 fluorodeoxyglucose in group A (13 patients)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Uptake of F-18 fluorodeoxyglucose in group B (13 patients)
Number of subjects: 60
Study: 1457484

Group type: EXPERIMENTAL
Intervention: Iopamidol-300
Number of subjects: 27

Group type: COMPARATOR
Intervention: Iopamidol-370
Number of subjects: 27
Study: 6487515

Group type: EXPERIMENTAL
Intervention: Adjuvant radiation 15 Grays in 10 fractions in 2 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no adjuvant radiation)
Number of subjects: 120
Study: 30040719

Group type: EXPERIMENTAL
Intervention: Moderate-to-high intensity aerobic exercise for 16 weeks
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Combined data from IG and CG
Number of subjects: 55
Study: 27471785

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Diabetes Support and Education (DSE)
Number of subjects: 2400
Study: 25028522

Group type: EXPERIMENTAL
Intervention: Intranasal insulin application
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23408502

Group type: EXPERIMENTAL
Intervention: Combination (ADF plus endurance exercise)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: ADF
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control
Number of subjects: 64
Study: 20529449

Group type: EXPERIMENTAL
Intervention: Local application of autologous bone marrow stem cells (ABMSC) concentrate in group I (n = 42)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard medical care in group II (n = 54, control)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Local application of ABMSC in group I
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Patients who failed ABMSC therapy
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: ABMSC therapy
Number of subjects: 96
Study: 19017387

Group type: EXPERIMENTAL
Intervention: artemether-lumefantrine (AL)
Number of subjects: 146

Group type: COMPARATOR
Intervention: dihydroartemisinin-piperaquine (DP)
Number of subjects: 146
Study: 16626379

Group type: EXPERIMENTAL
Intervention: Behind-the-Knee test (BTK test)
Number of subjects: 35
Study: 12620717

Group type: EXPERIMENTAL
Intervention: 2:1 coordination pattern training (1L:2R)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 2:1 coordination pattern training (2L:1R)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1:1 anti-phase frequency-scaled coordination task
Number of subjects: 16
Study: 10734696

Group type: EXPERIMENTAL
Intervention: Ultrasonography (USG) for measuring femoral head and neck antetorsion angle
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Surgical treatment for increased antetorsion in children with spastic cerebral palsy
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Surgical treatment for Perthes disease
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Surgical treatment for congenital hip dysplasia
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Corrective osteotomy of femoral proximal end
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Ultrasonography (USG) for assessment of femoral antetorsion
Number of subjects: 104
Study: 7745068

Group type: EXPERIMENTAL
Intervention: GnRHa/HMG/GH (18 IU on alternate days, total dose 72 IU)
Number of subjects: 14

Group type: COMPARATOR
Intervention: GnRHa/HMG placebo
Number of subjects: 14

Group type: COMPARATOR
Intervention: GnRHa/HMG placebo (previous cycles)
Number of subjects: 14
Study: 2117857

Group type: EXPERIMENTAL
Intervention: Allopurinol 600 mg/day for 60 days
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Allopurinol 900 mg/day for 60 days
Number of subjects: 307

Group type: COMPARATOR
Intervention: Benznidazole at conventional dosage regimens
Number of subjects: 307

Group type: COMPARATOR
Intervention: Nifurtimox at conventional dosage regimens
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 307

Group type: COMPARATOR
Intervention: Nitrofurans (conventional therapy)
Number of subjects: 307
Study: 7250461

Group type: EXPERIMENTAL
Intervention: Diflumidone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 0
Study: 30423452

Group type: EXPERIMENTAL
Intervention: Haplogroup B4
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Haplogroup B5
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Haplogroup D4b
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Haplogroup F
Number of subjects: 472
Study: 28869475

Group type: EXPERIMENTAL
Intervention: Attention Process Training‐II (APT‐II)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 46
Study: 26490296

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 448

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 448
Study: 24361805

Group type: EXPERIMENTAL
Intervention: Presence of pulmonary hypertension (PH) in patients with diastolic dysfunction grades 1, 2, and 3
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Transpulmonary pressure gradient (TPG) >12 mm Hg in HF patients with PH
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Survival rates in HF patients with PH
Number of subjects: 392
Study: 23000083

Group type: EXPERIMENTAL
Intervention: Endometriosis group (Group I)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (Group II)
Number of subjects: 240
Study: 19317815

Group type: EXPERIMENTAL
Intervention: HiMF training (HiMFT)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: LoMF training (LoMFT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: HiMF control (HiMFC)
Number of subjects: 55

Group type: COMPARATOR
Intervention: LoMF control (LoMFC)
Number of subjects: 55
Study: 17616788

Group type: EXPERIMENTAL
Intervention: 3000 mg calcium carbonate + 1400 IU cholecalciferol
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo (200 IU cholecalciferol)
Number of subjects: 122
Study: 15056835

Group type: EXPERIMENTAL
Intervention: Combination therapy (ACEI + ARB)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Monotherapy (ACEI or ARB)
Number of subjects: 106